Journal for ImmunoTherapy of Cancer

Journal Details

Journal for ImmunoTherapy of Cancer

ISSN : 20511426

P-ISSN :

CiteScore : 14.90

Impact Factor : 10.3

5 year IF : 13.864

Collection : Science Citation Index Expanded

Open Acess : YES

Acceptance rate : N/A

Publishing Model : N/A

Article Processing Charge : 1

First Response : N/A

First post-review decision : N/A

Submission to Acceptance : N/A

Acceptance to publication : N/A

PUBLICATION TYPE : Journals

COUNTRY : Country United Kingdom

Publisher :BMJ Publishing Group

publisher Address : BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND, WC1H 9JR

H-Index : 117

Coverage : 2013-2023

Homepage

Contact : info.jitc@bmj.com

Issues Per Year : 1

Frequency : Continuous publication

Transparent Peer Review : NO

Min Pages : 0

Max Pages : 0

Subject Area and Category

Biochemistry, Genetics and Molecular Biology
- Cancer Research
- Molecular Medicine
Immunology and Microbiology
- Immunology
Medicine
- Immunology and Allergy
- Oncology
Pharmacology, Toxicology and Pharmaceutics
- Pharmacology

About Journal

The Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field. Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.

Quartiles

Cancer Research

Molecular Medicine

Immunology

Immunology and Allergy

Oncology

Pharmacology

Documents per Year

Citations per Year

Comments

You need to login to add a comment.